Literature DB >> 9514918

Cloning and functional expression of a new aquaporin (AQP9) abundantly expressed in the peripheral leukocytes permeable to water and urea, but not to glycerol.

K Ishibashi1, M Kuwahara, Y Gu, Y Tanaka, F Marumo, S Sasaki.   

Abstract

A new member (AQP9) of the aquaporin family was identified from human leukocytes by homology cloning using PCR. A full length clone was obtained by screening human liver cDNA library. AQP9 encodes a 295-amino-acid protein with the amino acid sequence identity with AQP3 (48%), AQP7 (45%), and other aquaporins (approximately 30%), suggesting that AQP3, AQP7, and AQP9 belong to a subfamily of the aquaporin family. Injection of AQP9-cRNA into Xenopus oocytes stimulated the osmotic water permeability 7-folds with a low activation energy (4.2 kcal/mol) which was inhibited by 0.3 mM mercury chloride by 48%. AQP9 also facilitated urea transport 4-folds. However, in contrast to AQP3 and AQP7, AQP9 did not stimulate the glycerol permeability, suggesting a unique permeability character. Northern blot analysis revealed the high expression of 3.5-kb messages in peripheral leukocytes >> liver > lung = spleen, but not in thymus. The possible role of AQP9 in the immunological function of leukocytes is intriguing and the identification of AQP9 with unique permeability profile may expand our understanding of water and small solute transport in the body.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514918     DOI: 10.1006/bbrc.1998.8252

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  67 in total

Review 1.  What are aquaporins for?

Authors:  A E Hill; B Shachar-Hill; Y Shachar-Hill
Journal:  J Membr Biol       Date:  2004-01-01       Impact factor: 1.843

Review 2.  Aquaporins in the brain: from aqueduct to "multi-duct".

Authors:  Jérôme Badaut; Jean-François Brunet; Luca Regli
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

3.  Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changes.

Authors:  Petra Hrubá; Irena Brabcová; Faikah Gueler; Zdeněk Krejčík; Viktor Stránecký; Eva Svobodová; Jana Malušková; Wilfried Gwinner; Eva Honsová; Alena Lodererová; Rainer Oberbauer; Roman Zachoval; Ondřej Viklický
Journal:  Kidney Int       Date:  2015-07-15       Impact factor: 10.612

4.  Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance control.

Authors:  Amaia Rodríguez; Victoria Catalán; Javier Gómez-Ambrosi; Gema Frühbeck
Journal:  Cell Cycle       Date:  2011-05-15       Impact factor: 4.534

5.  Chemoresistant lung cancer stem cells display high DNA repair capability to remove cisplatin-induced DNA damage.

Authors:  Wai-Kin Yu; Zhigang Wang; Chi-Chun Fong; Dandan Liu; Tak-Chun Yip; Siu-Kie Au; Guangyu Zhu; Mengsu Yang
Journal:  Br J Pharmacol       Date:  2017-01-16       Impact factor: 8.739

6.  Differential diagnosis between freshwater drowning and saltwater drowning based on intrapulmonary aquaporin-5 expression.

Authors:  Takahito Hayashi; Yuko Ishida; Shinya Mizunuma; Akihiko Kimura; Toshikazu Kondo
Journal:  Int J Legal Med       Date:  2008-05-06       Impact factor: 2.686

7.  Osteoclast differentiation and function in aquaglyceroporin AQP9-null mice.

Authors:  Yangjian Liu; Linhua Song; Yiding Wang; Aleksandra Rojek; Søren Nielsen; Peter Agre; Jennifer M Carbrey
Journal:  Biol Cell       Date:  2009-03       Impact factor: 4.458

8.  Aquaporin biology and nervous system.

Authors:  Barbara Buffoli; Buffoli Barbara
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

9.  Integrative modeling of transcriptional regulation in response to antirheumatic therapy.

Authors:  Michael Hecker; Robert Hermann Goertsches; Robby Engelmann; Hans-Juergen Thiesen; Reinhard Guthke
Journal:  BMC Bioinformatics       Date:  2009-08-24       Impact factor: 3.169

10.  Aquaporins and glia.

Authors:  Roberta Albertini; Rossella Bianchi
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.